These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 23994301)
1. Evaluation of P-glycoprotein (abcb1a/b) modulation of [(18)F]fallypride in MicroPET imaging studies. Piel M; Schmitt U; Bausbacher N; Buchholz HG; Gründer G; Hiemke C; Rösch F Neuropharmacology; 2014 Sep; 84():152-8. PubMed ID: 23994301 [TBL] [Abstract][Full Text] [Related]
2. Cyclosporine, a P-glycoprotein modulator, increases [18F]MPPF uptake in rat brain and peripheral tissues: microPET and ex vivo studies. Laćan G; Plenevaux A; Rubins DJ; Way BM; Defraiteur C; Lemaire C; Aerts J; Luxen A; Cherry SR; Melega WP Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2256-66. PubMed ID: 18604533 [TBL] [Abstract][Full Text] [Related]
3. Imaging P-glycoprotein function in rats using [(11)C]-N-desmethyl-loperamide. Farwell MD; Chong DJ; Iida Y; Bae SA; Easwaramoorthy B; Ichise M Ann Nucl Med; 2013 Aug; 27(7):618-24. PubMed ID: 23572210 [TBL] [Abstract][Full Text] [Related]
4. PET-CT imaging with [(18)F]-gefitinib to measure Abcb1a/1b (P-gp) and Abcg2 (Bcrp1) mediated drug-drug interactions at the murine blood-brain barrier. Vlaming ML; Läppchen T; Jansen HT; Kivits S; van Driel A; van de Steeg E; van der Hoorn JW; Sio CF; Steinbach OC; DeGroot J Nucl Med Biol; 2015 Nov; 42(11):833-41. PubMed ID: 26264927 [TBL] [Abstract][Full Text] [Related]
5. Effect of a P-glycoprotein inhibitor, Cyclosporin A, on the disposition in rodent brain and blood of the 5-HT1A receptor radioligand, [11C](R)-(-)-RWAY. Liow JS; Lu S; McCarron JA; Hong J; Musachio JL; Pike VW; Innis RB; Zoghbi SS Synapse; 2007 Feb; 61(2):96-105. PubMed ID: 17117422 [TBL] [Abstract][Full Text] [Related]
6. Endogenous competition against binding of [(18)F]DMFP and [(18)F]fallypride to dopamine D(2/3) receptors in brain of living mouse. Rominger A; Wagner E; Mille E; Böning G; Esmaeilzadeh M; Wängler B; Gildehaus FJ; Nowak S; Bruche A; Tatsch K; Bartenstein P; Cumming P Synapse; 2010 Apr; 64(4):313-22. PubMed ID: 19957365 [TBL] [Abstract][Full Text] [Related]
7. Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec) across the mouse blood-brain barrier. Bihorel S; Camenisch G; Lemaire M; Scherrmann JM J Neurochem; 2007 Sep; 102(6):1749-1757. PubMed ID: 17696988 [TBL] [Abstract][Full Text] [Related]
8. Striatal and extrastriatal microPET imaging of D2/D3 dopamine receptors in rat brain with [¹⁸F]fallypride and [¹⁸F]desmethoxyfallypride. Constantinescu CC; Coleman RA; Pan ML; Mukherjee J Synapse; 2011 Aug; 65(8):778-87. PubMed ID: 21218455 [TBL] [Abstract][Full Text] [Related]
9. Spinal cord dopamine D2/D3 receptors: in vivo and ex vivo imaging in the rat using (18)F/(11)C-fallypride. Kaur J; Khararjian A; Coleman RA; Constantinescu CC; Pan ML; Mukherjee J Nucl Med Biol; 2014; 41(10):841-7. PubMed ID: 25199843 [TBL] [Abstract][Full Text] [Related]
10. Dopamine D3 receptor binding of (18)F-fallypride: Evaluation using in vitro and in vivo PET imaging studies. Mukherjee J; Constantinescu CC; Hoang AT; Jerjian T; Majji D; Pan ML Synapse; 2015 Dec; 69(12):577-91. PubMed ID: 26422464 [TBL] [Abstract][Full Text] [Related]
11. (18)F-FCWAY, a serotonin 1A receptor radioligand, is a substrate for efflux transport at the human blood-brain barrier. Liow JS; Zoghbi SS; Hu S; Hall MD; Hines CS; Shetty HU; Araneta MD; Page EM; Pike VW; Kreisl WC; Herscovitch P; Gottesman MM; Theodore WH; Innis RB Neuroimage; 2016 Sep; 138():134-140. PubMed ID: 27211474 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of dopamine D3 receptor antagonist 11C-GR218231 as PET tracer for P-glycoprotein. de Vries EF; Kortekaas R; van Waarde A; Dijkstra D; Elsinga PH; Vaalburg W J Nucl Med; 2005 Aug; 46(8):1384-92. PubMed ID: 16085598 [TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography studies on binding of central nervous system drugs and P-glycoprotein function in the rodent brain. Elsinga PH; Hendrikse NH; Bart J; van Waarde A; Vaalburg W Mol Imaging Biol; 2005; 7(1):37-44. PubMed ID: 15912274 [TBL] [Abstract][Full Text] [Related]
14. Enhanced cerebral uptake of receptor ligands by modulation of P-glycoprotein function in the blood-brain barrier. Doze P; Van Waarde A; Elsinga PH; Hendrikse NH; Vaalburg W Synapse; 2000 Apr; 36(1):66-74. PubMed ID: 10700027 [TBL] [Abstract][Full Text] [Related]
15. [¹⁸F]Altanserin and small animal PET: impact of multidrug efflux transporters on ligand brain uptake and subsequent quantification of 5-HT₂A receptor densities in the rat brain. Kroll T; Elmenhorst D; Matusch A; Celik AA; Wedekind F; Weisshaupt A; Beer S; Bauer A Nucl Med Biol; 2014 Jan; 41(1):1-9. PubMed ID: 24120220 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and Preclinical Evaluation of Three Novel Fluorine-18 Labeled Radiopharmaceuticals for P-Glycoprotein PET Imaging at the Blood-Brain Barrier. Savolainen H; Cantore M; Colabufo NA; Elsinga PH; Windhorst AD; Luurtsema G Mol Pharm; 2015 Jul; 12(7):2265-75. PubMed ID: 26043236 [TBL] [Abstract][Full Text] [Related]
17. P-Glycoprotein, not BCRP, Limits the Brain Uptake of [(18)F]Mefway in Rodent Brain. Choi JY; Song JS; Lee M; Cho WK; Chung J; Lyoo CH; Kim CH; Park J; Lee KC; Kim KM; Kang JH; Bae MA; Ryu YH Mol Imaging Biol; 2016 Apr; 18(2):267-73. PubMed ID: 26250653 [TBL] [Abstract][Full Text] [Related]
18. P-glycoprotein influence on the brain uptake of a 5-HT(2A) ligand: [(18)F]MH.MZ. Schmitt U; Lee DE; Herth MM; Piel M; Buchholz HG; Roesch F; Hiemke C; Lueddens H; Debus F Neuropsychobiology; 2011; 63(3):183-90. PubMed ID: 21304228 [TBL] [Abstract][Full Text] [Related]
19. Effect of cyclosporin A on the uptake of D3-selective PET radiotracers in rat brain. Tu Z; Li S; Xu J; Chu W; Jones LA; Luedtke RR; Mach RH Nucl Med Biol; 2011 Jul; 38(5):725-39. PubMed ID: 21718948 [TBL] [Abstract][Full Text] [Related]
20. Influence of P-Glycoprotein Inhibition or Deficiency at the Blood-Brain Barrier on (18)F-2-Fluoro-2-Deoxy-D-glucose ( (18)F-FDG) Brain Kinetics. Tournier N; Saba W; Goutal S; Gervais P; Valette H; Scherrmann JM; Bottlaender M; Cisternino S AAPS J; 2015 May; 17(3):652-9. PubMed ID: 25716150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]